Register
Login:
Share:
Email Facebook Twitter


ETF Investing made simple; CEO of justETF explains why


Scancell Holdings Share Price (SCLP)



Share Price Information for Scancell Holdings (SCLP)


Share Price: 14.375Bid: 14.00Ask: 14.75Change: 0.00 (0.00%)No Movement on Scancell Hldgs
Spread: 0.75Spread as %: 5.36%Open: 14.375High: 14.375Low: 14.375Yesterday’s Close: 14.375

Scancell Holdings Plc Ord 0.1P

Scancell Holdings is listed in the FTSE AIM All-Share
Scancell Holdings is part of the Medicine and Biotech Research sector






Share Price SpacerPrice
14.375

Share Price SpacerBid
14.00

Share Price SpacerAsk
14.75

Share Price SpacerChange
0%0.00

Share Price SpacerVolume
65,996

Share Price SpacerOpen
14.375

Share Price SpacerHigh
14.375

Share Price SpacerLow
14.375

Share Price SpacerClose
14.375

Share Price SpacerCurrency
GBX


Currency Issue Country Shares in Issue Market Capitalisation Market Size
GBX GB 261.56m £37.60m 10,000

52 Week High 21.50 52 Week High Date 7-MAR-2016
52 Week Low 13.00 52 Week Low Date 17-JUN-2016

# Trades Vol. Sold Vol. Bought PE Ratio Earnings Dividend Yield
5 41,000 24,996 -12.610 -1.14 0.00 0.00




Date
Time
Trade Prc
Volume
Buy/Sell
Bid
Ask
Value
 

21-Feb-17
13:03:07
14.13
41,000
Sell* 
14.00
14.75
5,793
Trade Type:
Ordinary

21-Feb-17
12:29:43
14.3852
17,378
Buy* 
14.00
14.75
2,500
Trade Type:
Ordinary

21-Feb-17
10:53:42
14.3852
2,557
Buy* 
14.00
14.75
367.83
Trade Type:
Ordinary




View more Scancell Holdings trades >>

Directors Deals for Scancell Holdings (SCLP)
Trade DateActionNotifierPriceCurrencyAmountHolding
10-Dec-13Notification of Holding
Trade Notifier Information for Scancell Holdings
Lindy Durrant held the position of CEO at Scancell Holdings at the time of this trade.
 Lindy Durrant
000
10-Dec-13Notification of Holding
Trade Notifier Information for Scancell Holdings
Richard Goodfellow held the position of Joint CEO at Scancell Holdings at the time of this trade.
 Richard Goodfellow
000
21-Oct-13Sell
Trade Notifier Information for Scancell Holdings
Lindy Durrant held the position of CEO at Scancell Holdings at the time of this trade.
 Lindy Durrant
30GBX100,0000
View more Scancell Holdings directors dealings >>



Date/TimeAuthorSubjectShare PriceOpinion
Tue 23:50james007bondRE: SCLP14.375No Opinion
Here's the text:

Published on Feb 21, 2017Scancell is a UK-based, cancer-focused, biotechnology company. Zacks Analyst John Vandermosten believes Scancell has shown exciting promise in the treatment of melanoma. Their drug triggers the patient’s own immune system to eradicate tumor cells, resulting in a 95% survival rate in the ongoing trial. Scancell has an impressive portfolio consisting of two platforms, and three compounds covering five cancer indications. Vandermosten sees strong… Read More
Tue 23:48james007bondRE: SCLP14.375Strong Buy
Here's the text:
Published on Feb 21, 2017Scancell is a UK-based, cancer-focused, biotechnology company. Zacks Analyst John Vandermosten believes Scancell has shown exciting promise in the treatment of melanoma. Their drug triggers the patient’s own immune system to eradicate tumor cells, resulting in a 95% survival rate in the ongoing trial. Scancell has an impressive portfolio consisting of two platforms, and three compounds covering five cancer indications. Vandermosten sees strong… Read More
Tue 23:44boomorbusticalvert14.375No Opinion
From what I can gather, it very much depends upon who is eventually appointed.
Tue 23:33icalvertRE: FDA Reform14.375No Opinion
Does anyone here have a view about whether there is a USA expert consensus that , as suggested here, oncology might be relatively untouched in the FDA Reform that is coming?

I note that the keywords for this piece were FDA and Politics.
Tue 23:33boomorbustBibio14.375No Opinion
Thanks very much for posting - good stuff
Tue 23:20BibioSCLP14.375No Opinion

Share prices shown are taken at time of message posting.
Thread ViewThread View
View more share chat for Scancell Holdings (SCLP) >>

Please login or register to post a message on Share Chat.








Share Price, Share Chat, Stock Market news at lse.co.uk
FREE Member Services
- Setup a personalised Watchlist and Virtual Portfolio.
- Gain access to LIVE real-time Regulatory News (RNS).
- View more Trades, Directors' Deals, and Broker Ratings.
Share Price, Share Chat, Stock Market news at lse.co.uk








Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.